North America Clinical Decision Support Systems Market By Component (Services, Hardware, and Software), By Product (Standalone CDSS, Integrated CDSS with CPOE & E),H),R),, Integrated E),H),R), with CDSS, and Others), By Delivery Mode (On-premise Systems, Web-based Systems, and Cloud-based Systems), By Application (Drug Allergy Alerts, Drug-drug Interactions, Clinical Guidelines, Drug Dosing Support, Clinical Reminders, and Others), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
The North America Clinical Decision Support Systems Market would witness market growth of 9.4% CAGR during the forecast period (2021-2027).
One of the key factors driving the market growth is the growing need for high-quality care and integrated, and robust technical solutions. Moreover, some of the key trends of the market are increasing adoption of information systems by hospitals and healthcare institutions, as well as beneficial efforts implemented by numerous governments throughout the world. Authorities such as the Food and Drug Administration (FDA) control the utilization of clinical decision support systems (CDSS).
Rapid advances in biotechnology and bioinformatics are encouraging data storage, management, and analytics platform enhancements and optimizations. Following R&D programs sponsored by major corporate investments, the industry is expected to see a substantial number of advancements. Integration of cloud computing and interoperability platforms with many systems would further facilitate a smooth operation and data flow, accelerating CDSS adoption.
The clinical decision support systems (CDSS) market in North America is driven by technological advancements in CDSS. In addition, the patients across the region are more concerned about their health as well as are more aware of the increasing technological advancements across the clinical decision support systems.
The US market dominated the North America Clinical Decision Support Systems Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $2.4 billion by 2027. The Canada market is expected to witness a CAGR of 11.9% during (2021 - 2027). Additionally, The Mexico market would experience a CAGR of 10.9% during (2021 - 2027).
Based on Component, the market is segmented into Services, Hardware, and Software. Based on Product, the market is segmented into Standalone CDSS, Integrated CDSS with CPOE & E.H.R., Integrated E.H.R. with CDSS, and Others. Based on Delivery Mode, the market is segmented into On-premise Systems, Web-based Systems, and Cloud-based Systems. Based on Application, the market is segmented into Drug Allergy Alerts, Drug-drug Interactions, Clinical Guidelines, Drug Dosing Support, Clinical Reminders, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), AllScripts Healthcare Solutions, Inc., General Electric (GE) Co. (GE Healthcare), NextGen Healthcare, Inc., Athenahealth, Inc. (Veritas Capital), Epic Systems Corporation, eClinicalWorks LLC, Change Healthcare, Inc., and Zynx Health, Inc. (Hearst Communications, Inc.).
Scope of the Study
Market Segments covered in the Report:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook